92
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate

, ORCID Icon, , , ORCID Icon &
Pages 357-359 | Published online: 04 Feb 2021

References

  • Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9
  • Li YK, Peng S, Li LQ, et al. Clinical and transmission characteristics of covid-19 - a retrospective study of 25 cases from a single thoracic surgery department. Curr Med Sci. 2020;40(2):295–300. doi:10.1007/s11596-020-2176-2
  • Abrams EM, Geert WJ, Yang CL. Asthma and COVID-19. CMAJ. 2020.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
  • Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178. doi:10.1183/09031936.00138707
  • Ishiura Y, Fujimura M, Ohkura N, et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate improves inspiratory capacity in patients with asthma-chronic obstructive pulmonary disease overlap. Int J Chron Obstruct Pulmon Dis. 2020;15:269–277. doi:10.2147/COPD.S231004